Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3
Disclaimer : Available as lyophilized (freeze-dried) powder for laboratory and in vitro research applications
The common side effects of B12 IV infusions include minor bruising at the catheter site, a cooling sensation during fluid delivery, and occasional lightheadedness
Cagrilintide: Long-acting amylin analog explained What cagrilintide is: Synthetic analog of human amylin hormone Also called "pramlintide long-acting" (related compound) Developed by Novo Nordisk Currently investigational (Phase 3 trials) Not yet FDA approved (as of 2024) Weekly subcutaneous injection Natural amylin background: Peptide hormone co-secreted with insulin Made by pancreatic beta cells Released after meals in response to nutrients Important satiety signal Regulates postprandial glucose Deficient in diabetes Why synthetic cagrilintide was developed: Natural amylin very short half-life (minutes) Impractical for treatment Cagrilintide engineered for long duration Weekly dosing vs multiple daily injections Better pharmacokinetics Enhanced stability Learn about peptides , how peptides work , and what are peptides used for at SeekPeptides
02 Review Your Care Pathway Review your comprehensive pathway.
US$ 22.09
US$ 24.61
US$ 28.30
US$ 24.44
US$ 22.55
US$ 20.31
US$ 27.93